Abstract Objective To assess the efficacy of golimumab (GLM) as a treatment option for juvenile idiopathic arthritis (JIA)-associated uveitis refractory to adalimumab (ADA). Methods Retrospective single-centre study including patients with JIA receiving GLM for active uveitis after failing ADA. JIA- and uveitis-related data. including intraocular inflammation. https://www.bekindtopets.com/mega-save-NHL-Florida-Panthers-Frozen-iPhone-13-Pro-MagSafe-Case-p93068-save-extra/